These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 483231)

  • 21. Sulfinpyrazone after myocardial infarction: no decision yet.
    Relman AS
    N Engl J Med; 1980 Dec; 303(25):1476-7. PubMed ID: 7432408
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of spontaneous platelet aggregation by sulfinpyrazone.
    Nenci GG; Agnelli G; Berrettini M; Parise P; Ballatori E
    Thromb Haemost; 1979 Aug; 42(2):621-5. PubMed ID: 505369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug trials in myocardial infarction. Lessons to be learned from the Anturane Reinfarction Trial.
    Sherry S
    Eur J Clin Pharmacol; 1980 Jun; 17(6):401-7. PubMed ID: 7398732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet drugs after myocardial infarction.
    Med Lett Drugs Ther; 1980 Mar; 22(6):25-6. PubMed ID: 7360108
    [No Abstract]   [Full Text] [Related]  

  • 25. Randomized trial of therapy with platelet antiaggregants for threatened stroke.
    The Canadian Cooperative Stroke Study Group
    Can Med Assoc J; 1980 Feb; 122(3):293-6. PubMed ID: 6989457
    [No Abstract]   [Full Text] [Related]  

  • 26. Drugs & dosages: Anturane.
    Occup Health Nurs; 1980 Apr; 28(4):48. PubMed ID: 6987588
    [No Abstract]   [Full Text] [Related]  

  • 27. Anturane reinfarction trial.
    Evans DW
    Lancet; 1978 Aug; 2(8085):366-7. PubMed ID: 79725
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet aggregation and atherosclerosis.
    Valladares BK; Lemberg L
    Heart Lung; 1986 Mar; 15(2):211-4. PubMed ID: 3633253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Platelet anti-aggregant drugs and ischemic cardiopathy: evaluation of the effect on platelet aggregation and on antithrombin III].
    Avellone G; Mandalà V; Novo S; Pinto A; Riolo FP; Davì G; Raneli G
    Boll Soc Ital Cardiol; 1981; 26(8):697-712. PubMed ID: 6289854
    [No Abstract]   [Full Text] [Related]  

  • 30. Preventing death after myocardial infarction.
    Horwitz DL
    Compr Ther; 1980 Jun; 6(6):3-4. PubMed ID: 7379491
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
    Thiele R
    Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention of death from myocardial infarction by aspirin and other platelet active drugs.
    Elwood PC
    Clin Cardiol; 1979 Aug; 2(4):241-5. PubMed ID: 400517
    [No Abstract]   [Full Text] [Related]  

  • 33. [Personal experience with the administration of sulfinpyrazone to patients with kidney failure].
    Opatrný K; Cepelák V; Opatrný K; Valenta J; Cepeláková H; Sefrna F
    Vnitr Lek; 1986 Jul; 32(7):673-80. PubMed ID: 3526712
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug reduces incidence of sudden cardiac death.
    Am Fam Physician; 1980 Apr; 21(4):179, 182. PubMed ID: 7377063
    [No Abstract]   [Full Text] [Related]  

  • 35. Sulfinpyrazone after myocardial infarction.
    N Engl J Med; 1978 Jun; 298(22):1257-9. PubMed ID: 349383
    [No Abstract]   [Full Text] [Related]  

  • 36. More on sulfinpyrazone after myocardial infarction.
    Hood WB
    N Engl J Med; 1982 Apr; 306(16):988-9. PubMed ID: 7038499
    [No Abstract]   [Full Text] [Related]  

  • 37. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
    Verdecchia P
    G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of anturan in patients with ischemic heart disease with a history of acute myocardial infarction].
    Bokarev IN; Golikov AP; Liusov VA; Ptushkin VV; Zvereva TV
    Klin Med (Mosk); 1987 Oct; 65(10):29-32. PubMed ID: 3431051
    [No Abstract]   [Full Text] [Related]  

  • 39. A serial study of platelet reactivity throughout the first six months after myocardial infarction: its modification by sulphinpyrazone.
    Kubik MM; Richardson SG
    Postgrad Med J; 1987 May; 63(739):351-6. PubMed ID: 3118351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of Anturane and aspirin on thrombocyte aggregation].
    Ciko Z; Stanimirović D
    Vojnosanit Pregl; 1984; 41(5):341-5. PubMed ID: 6516242
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.